220
Participants
Start Date
May 23, 2017
Primary Completion Date
March 31, 2021
Study Completion Date
June 30, 2021
Losartan
50mg once per day for two weeks,followed by 100mg once per day for 46 weeks if increased dose tolerated
Placebo
one capsule per day for two weeks, followed by two capsules per day for 46 weeks
New York University School of Medicine, New York
Weill Cornell Medicine, New York
Mount Sinai National Jewish Health Respiratory Institute; Icahn School of Medicine, New York
Columbia University Medical Center, New York
University of Pittsburgh Medical Center, Pittsburgh
Temple University, Philadelphia
Duke University Medical Center, Durham
University of Florida College of Medicine, Jacksonville
University of South Florida, Tampa
University of Alabama at Birmingham, Birmingham
St. Vincent Hospital and Health Care Center, Inc., Indianapolis
University of Illinois at Chicago, Chicago
Northwestern University, Chicago
Rush University Medical Center, Chicago
University of Chicago Hospitals, Chicago
St. Louis University School of Medicine, St Louis
St. Louis Asthma Clinical Research Center - Washington University School of Medicine, St Louis
University of Kansas Medical Center, Kansas City
Louisiana State University, New Orleans
Baylor College of Medicine, Houston
National Jewish Medical and Research Center, Denver
University of Arizona, Tucson
University of California at San Diego, San Diego
University of California at San Francisco, San Francisco
Pacific Northwest Airways - VA Puget Sound Healthcare System, Seattle
Western Connecticut Health Network, Danbury
University of Michigan, Ann Arbor
Vermont Lung Center at The University of Vermont, Colchester
Lead Sponsor
University of Pittsburgh
OTHER
JHSPH Center for Clinical Trials
OTHER